#商道创投网 · Investment and Financing News # SynTao Venture Capital Network learned on February 10, 2022; exoskeleton robot company ChengTian Technology received a round of financing of 100 million yuan, led by Dachen Caizhi,

#商道创投网 · Investment and Financing News # SynTao Venture Capital Network learned on February 10, 2022; exoskeleton robot company ChengTian Technology received a round of financing of 100 million yuan, led by Dachen Caizhi, Anxin Securities, Poly Capital, and old shareholder Lanchi Venture Capital. This round of financing will be used to enhance the operation capabilities of enterprise groups, deepen cooperation with top international research institutions and clinical institutions, increase investment in products, talents, technologies and supply chains, and enrich the C-end product matrix.

After completing the A round of financing in March 2021, ChengTian Technology applied the exoskeleton robot UGO for central neuropathy (hemiplegia, paraplegia, cerebral palsy, etc.) and obtained the NMPA Medical Device Class II certificate. Through the "intent detection" technology, UGO can realize active, passive, active-passive combination and other training modes to help paraplegic and hemiplegic patients due to central nervous system injury to carry out sports rehabilitation.